Items tagged with Treatment
‘Patients are falling through the cracks’: drug costs hinder India’s response to TB (post)
The country has the world’s largest number of multi-drug-resistant cases – but doctors and activists warn patients are going undiagnosed and untreated.
PAN-TB collaboration to advance investigational TB drug regimens to Phase 2 clinical trials (post)
Public-private collaboration to evaluate five antimicrobial agents across two combination regimens for treating both drug-susceptible and drug-resistant forms of TB with shorter treatment durations.
Tufts scientists use artificial intelligence to improve TB treatments (post)
Imagine you have 20 new compounds that have shown some effectiveness in treating a disease like tuberculosis (TB), which affects 10 million people worldwide and kills 1.5 million each year. You know that to treat the disease effectively, patients will need a combination of three or four drugs because TB bacteria behave differently in different environments—and in some cases, evolve to become drug-resistant.
Digital medication device improves quality of life, reduces costs for TB patients (post)
Patients with pulmonary tuberculosis (TB) exhibited an improvement in quality of life and a reduction in treatment costs by utilizing a digital medication event reminder monitor (MERM).
Smart pill box can help with TB treatment, but it’s not for everyone (post)
Tuberculosis (TB) can be cured, but completing TB treatment can sometimes be difficult. Treatment for drug-susceptible forms of TB takes six months and some of the medicines have side effects. Treatment of drug-resistant TB typically takes more than six months and the risk of side effects is substantially higher.
Optimal time to initiate antiretroviral therapy after pulmonary TB treatment in pediatric patients (post)
These study findings support the World Health Organization’s recommendation to initiate antiretroviral therapy in HIV-positive pediatric patients within 2 weeks of initiating treatment for pulmonary tuberculosis.
Webinar: Choosing TB regimens to advance to late-stage clinical trials (post)
RESIST-TB will host a webinar on 24 October 2022 'Choosing TB regimens to advance to late-stage clinical trials: Using interim (Bayesian) analyses to increase likelihood of success'.
Shorter treatment effective for drug-resistant TB (post)
Two treatment regimens for multidrug-resistant TB, containing the first new drug to have been discovered for the disease in 40 years, are more effective than a previously recommended treatment, according to results from a global trial led by UCL researchers.
TB treatment can be cut to two months for some, finds landmark study (post)
Some cases of TB can be successfully treated in as little as two months – a third of the current standard of six months in South Africa and most other countries. This is according to early findings from the landmark TRUNCATE TB trial presented at 2022 Union World Conference on Lung Health.
Linezolid at lower doses may be more tolerable for multidrug-resistant TB (post)
Improved outcomes and increased treatment tolerability to linezolid were observed in patients with multidrug-resistant tuberculosis who switched to a lower dose.
Page 66 of 108 · Total posts: 0
←First 65 66 67 Last→